From its cardiovascular divisions, Medtronic brought in $3.1 billion for an increase of 6.1%—driven in part by the launches ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.

Medtronic has announced new clinical study results showcasing a high durable lesion formation rate for the PulseSelect pulsed ...

The widespread adoption of PulseSelect also continues, with more than 10,000 cases having been performed worldwide.

The PulseSelect™ Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter. The healthcare company said it is now the first and only company with two ...